A framework for image-based classification of mitotic cells in asynchronous populations
High content screening (HCS) has emerged an important tool for drug discovery because it combines rich readouts of cellular responses in a single experiment. Inclusion of cell cycle analysis into HCS is essential to identify clinically suitable anticancer drugs that disrupt the aberrant mitotic acti...
Saved in:
Published in: | Assay and drug development technologies Vol. 10; no. 2; p. 161 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
01-04-2012
|
Subjects: | |
Online Access: | Get more information |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | High content screening (HCS) has emerged an important tool for drug discovery because it combines rich readouts of cellular responses in a single experiment. Inclusion of cell cycle analysis into HCS is essential to identify clinically suitable anticancer drugs that disrupt the aberrant mitotic activity of cells. One challenge for integration of cell cycle analysis into HCS is that cells must be chemically synchronized to specific phases, adding experimental complexity to high content screens. To address this issue, we have developed a rules-based method that utilizes mitotic phosphoprotein monoclonal 2 (MPM-2) marker and works consistently in different experimental conditions and in asynchronous populations. Further, the performance of the rules-based method is comparable to established machine learning approaches for classifying cell cycle data, indicating the robustness of the features we use in the framework. As such, we suggest the use of MPM-2 analysis and its associated expressive features for integration into HCS approaches. |
---|---|
AbstractList | High content screening (HCS) has emerged an important tool for drug discovery because it combines rich readouts of cellular responses in a single experiment. Inclusion of cell cycle analysis into HCS is essential to identify clinically suitable anticancer drugs that disrupt the aberrant mitotic activity of cells. One challenge for integration of cell cycle analysis into HCS is that cells must be chemically synchronized to specific phases, adding experimental complexity to high content screens. To address this issue, we have developed a rules-based method that utilizes mitotic phosphoprotein monoclonal 2 (MPM-2) marker and works consistently in different experimental conditions and in asynchronous populations. Further, the performance of the rules-based method is comparable to established machine learning approaches for classifying cell cycle data, indicating the robustness of the features we use in the framework. As such, we suggest the use of MPM-2 analysis and its associated expressive features for integration into HCS approaches. |
Author | Brinkley, Bill R Szafran, Adam T Slattery, Scott D Mancini, Michael A Newberg, Justin Y Hall, Rebecca M |
Author_xml | – sequence: 1 givenname: Scott D surname: Slattery fullname: Slattery, Scott D organization: Molecular and Cellular Biology Department, Baylor College of Medicine, Houston, Texas 77030, USA – sequence: 2 givenname: Justin Y surname: Newberg fullname: Newberg, Justin Y – sequence: 3 givenname: Adam T surname: Szafran fullname: Szafran, Adam T – sequence: 4 givenname: Rebecca M surname: Hall fullname: Hall, Rebecca M – sequence: 5 givenname: Bill R surname: Brinkley fullname: Brinkley, Bill R – sequence: 6 givenname: Michael A surname: Mancini fullname: Mancini, Michael A |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22084958$$D View this record in MEDLINE/PubMed |
BookMark | eNo1j0lLxDAYQIMozqJHr5I_0Jq1X3ocBh2FAS-KxyHNotE2KUmLzL9XXE7v8njwVug0pugQuqKkpkS1N9pONSOU1oS3cIKWVEqoFGWwQKtS3glhhIM4RwvGiBKtVEv0ssE-68F9pvyBfco4DPrVVZ0uzmLT61KCD0ZPIUWcPB7ClKZgsHF9X3CIWJdjNG85xTQXPKZx7n_ccoHOvO6Lu_zjGj3f3T5t76v94-5hu9lXRqhmqlpJnYQGhKHAwbTSKKVBig4IVaChodZry5lSygndEU6kYdR2AMQKxxlbo-vf7jh3g7OHMX8P5OPh_5B9AV1HUxw |
CitedBy_id | crossref_primary_10_3390_biomedicines10040779 crossref_primary_10_1038_s41598_022_09180_2 crossref_primary_10_1089_adt_2016_740 crossref_primary_10_1002_npr2_12221 crossref_primary_10_1371_journal_pone_0114749 crossref_primary_10_1016_j_stem_2019_08_005 crossref_primary_10_1177_0192623316629805 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1089/adt.2011.0397 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1557-8127 |
ExternalDocumentID | 22084958 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIDDK NIH HHS grantid: K12DK083014 – fundername: NCI NIH HHS grantid: P30 CA125123 – fundername: NIDDK NIH HHS grantid: P30 DK56338 – fundername: NIEHS NIH HHS grantid: RC2 ES018789 – fundername: NIEHS NIH HHS grantid: 1RC2ES018789-01 – fundername: NICHD NIH HHS grantid: U54 HD007495 – fundername: NIDDK NIH HHS grantid: P30 DK056338 |
GroupedDBID | --- 0R~ 1-M 23N 34G 39C 4.4 5GY ABBKN ABJNI ACGFS ACIWK ACPRK ADBBV AENEX AFRAH ALMA_UNASSIGNED_HOLDINGS BNQNF CAG CGR COF CS3 CUY CVF EBS ECM EIF EJD EMOBN F5P IAO IER IHR IM4 INH INR ITC MV1 NPM NQHIM O9- P2P PQQKQ RIG RML UE5 |
ID | FETCH-LOGICAL-c486t-951e57674c1737c95c88a754b70187a761dfad32888e4ab0305c21db770d4e322 |
IngestDate | Sat Sep 28 07:50:46 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c486t-951e57674c1737c95c88a754b70187a761dfad32888e4ab0305c21db770d4e322 |
OpenAccessLink | https://europepmc.org/articles/pmc3323936?pdf=render |
PMID | 22084958 |
ParticipantIDs | pubmed_primary_22084958 |
PublicationCentury | 2000 |
PublicationDate | 2012-Apr |
PublicationDateYYYYMMDD | 2012-04-01 |
PublicationDate_xml | – month: 04 year: 2012 text: 2012-Apr |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Assay and drug development technologies |
PublicationTitleAlternate | Assay Drug Dev Technol |
PublicationYear | 2012 |
References | 7749193 - Mol Biol Cell. 1995 Jan;6(1):119-34 7690961 - Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8407-11 7569953 - Science. 1995 Oct 6;270(5233):86-90 19854275 - J Struct Biol. 2010 Apr;170(1):1-9 6379644 - Proc Natl Acad Sci U S A. 1984 Jul;81(14):4439-43 16602586 - IEEE Trans Biomed Eng. 2006 Apr;53(4):762-6 19713763 - Cell Cycle. 2009 Sep 15;8(18):2984-94 12637748 - Science. 2003 Mar 14;299(5613):1743-7 12719470 - J Cell Biol. 2003 Apr 28;161(2):267-80 15499654 - Cell Motil Cytoskeleton. 2004 Dec;59(4):249-63 20863917 - Biochim Biophys Acta. 2010 Oct-Dec;1799(10-12):829-39 8900469 - Cytometry. 1996 Apr 1;23(4):272-8 9378753 - J Cell Sci. 1997 Sep;110 ( Pt 17):2013-25 6574461 - Proc Natl Acad Sci U S A. 1983 May;80(10):2926-30 2662192 - Proc Natl Acad Sci U S A. 1989 Jul;86(13):4982-6 8019000 - Mol Biol Cell. 1994 Feb;5(2):135-45 19797680 - Genome Res. 2009 Nov;19(11):2113-24 20360735 - Nature. 2010 Apr 1;464(7289):721-7 17435170 - J Biomol Screen. 2007 Jun;12(4):490-6 1506421 - J Cell Sci. 1992 Jul;102 ( Pt 3):387-92 |
References_xml | |
SSID | ssj0020374 |
Score | 2.007011 |
Snippet | High content screening (HCS) has emerged an important tool for drug discovery because it combines rich readouts of cellular responses in a single experiment.... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 161 |
SubjectTerms | Algorithms Anaphase - physiology Aurora Kinases Automation Cell Cycle Cell Nucleus - ultrastructure Cells - classification Coloring Agents Cytokinesis - physiology Cytological Techniques DNA - chemistry High-Throughput Screening Assays - methods Humans Image Processing, Computer-Assisted - methods Immunochemistry Microscopy Mitosis - physiology Protein-Serine-Threonine Kinases - metabolism Reproducibility of Results Support Vector Machine Tissue Fixation |
Title | A framework for image-based classification of mitotic cells in asynchronous populations |
URI | https://www.ncbi.nlm.nih.gov/pubmed/22084958 |
Volume | 10 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jj9owFLagvfQy6jKd6SofKi4QlYQkfjkiSsWlFRJU0xvylhHSkEEFDvTX93mJE6iqTg-9RMgWKMn7_Bbz-XuEfMjjkmclqEiD5BFG_DISDKtWLmAkWM5ELG3rhAX7-h0-TdNpp1N3amrG_qulcQxtbU7O_oO1w4_iAH5Gm-MVrY7XB9l93C9rvpWlEK436DEiE6xUX5pU2XCDQp64wQVtJFvN_r1lxvLdsZJGMNdQY7ehu9euncSiSbmTbVI_Drf1uSvLKtjXO_UtbuLizmp4OlKZlYIILGN0sTW_zLYVq_ohs1785PggTuBA8U1D5p5x90-JB4bfzvUbF4YBEvgu2jvbDCNk7LQBgjcetlCXtFxr7ETbf3P5QzCKqVztvR7ryPF9W6bebqytk2QIWA7C32fPFLjrqS7pYj5lUu7Jl1DUG_0er92Kd_Lx5D6M0rT_7lnVYrOX5VNy4csOOnZ4eUY6unpOenOnW34c0GVzDG83oD06bxTNjy_IzZgGUFEEFW2Bip6Cit6X1IOKWlDRdUXboKItUF2Sb5-ny8ks8h05IplCvo8wHdeZkX-SMRsxWWQSgLMsNcsbGGd5rEquRgkA6JQLE0xkEivB2FClGmPHS_Kouq_0NaFCpDkIKCSUSapzgR6jiIVkaSEl5Ll4Ra7cC1ttnezKqn6Vr_8484Y8aYD2ljwucU3rd6S7U4f31mq_AApncUI |
link.rule.ids | 782 |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+framework+for+image-based+classification+of+mitotic+cells+in+asynchronous+populations&rft.jtitle=Assay+and+drug+development+technologies&rft.au=Slattery%2C+Scott+D&rft.au=Newberg%2C+Justin+Y&rft.au=Szafran%2C+Adam+T&rft.au=Hall%2C+Rebecca+M&rft.date=2012-04-01&rft.eissn=1557-8127&rft.volume=10&rft.issue=2&rft.spage=161&rft_id=info:doi/10.1089%2Fadt.2011.0397&rft_id=info%3Apmid%2F22084958&rft_id=info%3Apmid%2F22084958&rft.externalDocID=22084958 |